Related Experiment Video
Updated: Jan 1, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
Basal repression of BRCA1 by multiple E2Fs and pocket proteins at adjacent E2F sites
Ranjit S Bindra1, Peter M Glazer
1Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut 06520-8040, USA.
Researchers identified how E2F4 and pocket proteins (p130/p107) repress the BRCA1 gene promoter. This discovery enhances understanding of tumor suppressor gene regulation and may lead to strategies to restore BRCA1 expression in cancers.
Area of Science:
- Molecular Biology
- Cancer Genetics
- Gene Regulation
Background:
- BRCA1 is a critical tumor suppressor gene frequently downregulated in various cancers.
- Mechanisms of BRCA1 transcriptional regulation in vivo are not fully understood.
- Hypoxia, a tumor microenvironment stress, induces E2F-dependent BRCA1 repression.
Purpose of the Study:
- To investigate the molecular mechanisms of BRCA1 transcriptional regulation in human cells.
- To identify specific transcription factors and co-factors binding the BRCA1 promoter.
- To elucidate the role of E2F family members and pocket proteins in BRCA1 gene expression.
Main Methods:
- Quantitative chromatin immunoprecipitation (ChIP) analysis to detect protein binding to the BRCA1 promoter.
- Analysis of E2F family members (E2F1, E2F4) and pocket proteins (p130, p107, Rb) occupancy.
- Investigation of binding site requirements at the two adjacent E2F sites in the proximal promoter.
Main Results:
- Multiple E2Fs and associated factors bind the BRCA1 promoter at two adjacent E2F sites.
- E2F1 and E2F4 bind simultaneously, with E2F4 being predominant in log-phase cells.
- E2F4/p130/p107 complexes, but not Rb, were found to basally repress the BRCA1 promoter, requiring intact E2F sites.
Conclusions:
- Provides a detailed molecular understanding of BRCA1 transcriptional regulation by E2Fs and pocket proteins.
- Identifies E2F4 and p130/p107 complexes as key basal repressors of BRCA1 expression in vivo.
- Findings may inform strategies to disrupt these repressive interactions and restore BRCA1 expression in tumors.
Related Concept Videos
Long-patch Base Excision Repair
Negative Regulator Molecules
Restarting Stalled Replication Forks
Abnormal Proliferation
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Replicative Cell Senescence

